By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Schneider Shorts 20.06.2025 – Greatest Italian of All Times honoured in Rome, a Turkish kleptomaniac busted, Nobel scammer and his Ajan get Emirates money, Elsevier corrects some past mistakes, and other limits to publication ethics.
Schneider Shorts 2.08.2024 – Two British stem cell biotechs in trouble, a baldness cure found in Pakistan, papermill clean-up in Vietnam and Thailand, a guide on finding papermill experts, Kosta’s first retraction, and finally, a Polish chemist trolls back!
Schneider Shorts 2.02.2024 – Three stories about Dana Farber (including a Nobelist!), two stories about the Lille papermille (including a game!), with an “honest” plant scientist, doctors being rewarded, amazing corrections and informative retractions, and how another Nobelist’s cell therapy business ended up unsold.
Schneider Shorts 1.09.2023 – how not to deal with rogue student, fraudster sanctioned despite unaffected conclusions, Nobelist gets two more retractions, with a wandering XRD spectrum, Swedish rector under investigation, British medical elites and their businesses, Japanese comedy neuroscience, and finally, the certain direction russian science must be sent to.
Schneider Shorts 18.08.2023 – Australian university outsources faculty affairs to Elsevier, Elsevier editor reports sleuth for misconduct, Mexican fraudster’s post-mortem retractions, more retractions in Dresden, with lying russians, Vicker’s Curse striking twice, and finally, Nobelist and struck-off dentist sell business for many millions.
How the Nobel Prize winner Sir Martin Evans and the lying crook Ajan Reginald almost succeeded, were it not for Patricia Murray.
In this 3rd instalment of her Celixir investigation, Patricia Murray learns whose side the British authority MHRA is on. Not the patients’, and certainly not on the side of facts.
Liverpool professor Patricia Murray continues investigating shady dealings of the regmed company Celixir, owned by struck-off dentist Ajan Reginald and Nobelist Sir Martin Evans
Patricia Murray uncovers the business secrets of the Nobelist Martin Evans and his partner Ajan Reginald. It seems the magic iMP cells used to treat patients in Greece were drawn from the blood of patients in Swansea, for the purpose of a secret PhD thesis. There is no serious science behind it, only serious investor money and a fraudulent patent.
Sir Martin Evans, winner of Nobel prize 2007, founded in 2009 the stem cell start-up Celixir, together with a struck-off dentist Ajan Reginald. With the help of the British heart surgeon Stephen Westaby, they ran a very profitable clinical trial in Greece, which now moved into UK.
For Better Science